20.04.2020 • Topics

Flow Chemistry: A Mature Technology still on the Rise

The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.

© isak55/Shutterstock
© isak55/Shutterstock

Flow chemistry or milli- and micro reaction technology (MRT) is a platform that can offer enormous advantages in this respect. But MRT has not yet achieved the status in fine chemicals and active ingredient manufacturing that one might expect. What are the reasons for this reluctance?
CHEManager asked executives and industry experts dealing with flow che­m­-
istry so share their opinion on why some industry sectors are so reluctant in adopting continuous production processes. We wanted to know:

  • How would you define the essence of flow chemistry?
  • Which factors are affecting the global flow chemistry market and the implementation of flow chemistry in the industry?
  • Should there be simplified approval procedures for flow chemistry processes or plants, and is the technology sufficiently covered in academic education?

Read the insightful answers of the ­experts here.

Philippe Robin
CEO and co-founder, Alysophil

Shawn Conway
Director of Engineering, Cambrex High Point

André de Vries
Commercial Director, Innosyn

Dirk Kirschneck
CEO, Microinnova

Luigi Vaccaro
Professor, Laboratory of Green Synthetic Organic Chemistry, Dipartimento di Chimica, Biologia e Biotecnologie, Università di Perugia

Duncan Guthrie
Managing Director, Vapourtec

Charlotte Wiles
CEO, Chemtrix

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read